Form D/A — Elucid Bioimaging Inc.
0002080612-26-000057 · filed Oct 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $79,999,999
- Reported amount sold
- $56,235,000
- Minimum investment
- $0
- Investors
- 20
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Elucid Bioimaging Inc.
- CIK
- 1585931
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2 PARK PLAZA
BOSTON, MA 02116 - Phone
- 617-329-9487
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Blake Richards · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Scott Huennekens · DirectorBoston, MA Find on LinkedIn ↗
-
Michael Lesh · DirectorBoston, MA Find on LinkedIn ↗
-
Richard Kuntz · DirectorBoston, MA Find on LinkedIn ↗
-
Evan Melrose · DirectorBoston, MA Find on LinkedIn ↗
-
Shamiram Feinglass · DirectorBoston, MA Find on LinkedIn ↗
-
Kelly Huang · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Rajesh Panda · DirectorBoston, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗